China Polymerase Chain Reaction Market Size & Outlook
China polymerase chain reaction market, 2018-2030 (US$M)
Related Markets
China polymerase chain reaction market highlights
- The China polymerase chain reaction market generated a revenue of USD 1,874.0 million in 2023 and is expected to reach USD 1,304.2 million by 2030.
- The China market is expected to grow at a CAGR of -5% from 2024 to 2030.
- In terms of segment, conventional pcr was the largest revenue generating type in 2023.
- Conventional PCR is the most lucrative type segment registering the fastest growth during the forecast period.
Polymerase chain reaction market data book summary
| Market revenue in 2023 | USD 1,874.0 million |
| Market revenue in 2030 | USD 1,304.2 million |
| Growth rate | -5% (CAGR from 2023 to 2030) |
| Largest segment | Conventional pcr |
| Fastest growing segment | Conventional PCR |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Conventional PCR |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Qiagen NV, Roche Holding AG ADR, Standard BioTools Inc, Stilla, Microsynth |
Other key industry trends
- In terms of revenue, China accounted for 6.0% of the global polymerase chain reaction market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China polymerase chain reaction market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 815.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Polymerase Chain Reaction Market Scope
Polymerase Chain Reaction Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China polymerase chain reaction market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to polymerase chain reaction market will help companies and investors design strategic landscapes.
Conventional pcr was the largest segment with a revenue share of 5.15% in 2023. Horizon Databook has segmented the China polymerase chain reaction market based on conventional pcr covering the revenue growth of each sub-segment from 2018 to 2030.
In addition, rising strategic initiatives such as licensing, partnerships, and collaboration to manufacture or distribute PCR products in different countries are anticipated to drive the market. The country can screen 51 million people daily. Moreover, with increasing homebased tests, the market has observed unprecedented opportunities.
The number of new cases has decreased, and most patients have recovered. China, one of the world’s largest chemical producers, expedited the development of testing kits. China plays a crucial role in sending supplies for testing to other countries.
More than 100 companies in China are selling kits to European countries. Nanjing Liming Bio-products produces around 600,000 kits per day and became the first company in the country to gain emergency approval to sell its real-time PCR tests in the U.S.
Reasons to subscribe to China polymerase chain reaction market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China polymerase chain reaction market databook
-
Our clientele includes a mix of polymerase chain reaction market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China polymerase chain reaction market , including forecasts for subscribers. This country databook contains high-level insights into China polymerase chain reaction market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China polymerase chain reaction market size, by type, 2018-2030 (US$M)
China Polymerase Chain Reaction Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
